LAKE · XBRL financial data
Lakeland Industries financial statements, every quarter
The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (LAKE's year ends in late January)
| In millions of dollars | Oct 31, 2023 | Jan 31, 2024 | Apr 30, 2024 | Jul 31, 2024 | Oct 31, 2024 | Jan 31, 2025 | Apr 30, 2025 | Jul 31, 2025 | Oct 31, 2025 | Jan 31, 2026 | Apr 30, 2026 | Jul 31, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32 | 31* | 36 | 39 | 46 | 47* | 47 | 52 | 48 | 46* | 47 | 50 |
| Cost of revenue | 18 | 20* | 20 | 23 | 27 | 28* | 31 | 34 | 33 | 31* | 33 | 32 |
| Gross profit | 13 | 11* | 16 | 15 | 19 | 19* | 16 | 19 | 14 | 15* | 15 | 19 |
| Total operating expenses | 10 | 15* | 14 | 17 | 18 | 19* | 20 | 19 | 20 | 17* | 19 | 21 |
| Other operating income (expense) | — | year only | — | — | — | — | — | — | — | — | — | — |
| Operating income (loss) | 4 | (3)* | 2 | (2) | 1 | (11)* | (5) | (4) | (2) | (5)* | 2 | (3) |
| Interest expense | 0 | 0* | 0 | 0 | 0 | 1* | 1 | 0 | 1 | 1* | 1 | 1 |
| Other income (expense) | (0) | 4* | 0 | 0 | (0) | 0* | 0 | 0 | (0) | (0)* | 0 | 0 |
| Income tax expense (benefit) | 1 | 1* | 0 | (0) | 0 | (0)* | (1) | (5) | 14 | 0* | 1 | 1 |
| Net income (loss) | 3 | (1)* | 2 | (1) | 0 | (18)* | (4) | 1 | (16) | (6)* | 0 | (5) |
| Earnings per share, basic USD per share | 0.35 | — | 0.22 | (0.19) | 0.01 | (2.45)* | (0.41) | 0.08 | (1.64) | — | 0.04 | (0.50) |
| Earnings per share, diluted USD per share | 0.34 | — | 0.22 | (0.19) | 0.01 | — | (0.41) | 0.08 | (1.64) | (0.68)* | 0.04 | (0.50) |
| Weighted average shares, basic millions of shares | 7,429 | — | 7 | 7 | 7 | 8* | 9 | 10 | — | — | 10 | 10 |
| Weighted average shares, diluted millions of shares | 7,614 | — | 8 | 7 | 8 | 7* | 9 | 10 | 10 | 9* | 10 | 10 |
Balance sheet
CSVFiscal quarters (LAKE's year ends in late January)
| In millions of dollars | Oct 31, 2023 | Jan 31, 2024 | Apr 30, 2024 | Jul 31, 2024 | Oct 31, 2024 | Jan 31, 2025 | Apr 30, 2025 | Jul 31, 2025 | Oct 31, 2025 | Jan 31, 2026 | Apr 30, 2026 | Jul 31, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | 26 | 25 | 28 | 25 | 16 | 17 | 19 | 18 | 17 | 13 | 17 | 18 |
| Short-term investments | — | 2 | — | — | — | — | — | — | — | — | — | — |
| Accounts receivable | 18 | 19 | 22 | 23 | 27 | 28 | 28 | 31 | 30 | 32 | 31 | 32 |
| Inventory | 54 | 51 | 56 | 68 | 73 | 83 | 86 | 90 | 88 | 83 | 78 | 75 |
| Total current assets | 104 | 102 | 114 | 129 | 125 | 137 | 141 | 147 | 143 | 134 | 137 | 137 |
| Property and equipment, net | 9 | 11 | 12 | 13 | 13 | 14 | 15 | 14 | 12 | 12 | 12 | 12 |
| Right-of-use asset | 10 | 11 | 12 | 12 | 14 | 14 | 14 | 9 | 11 | 11 | 10 | 10 |
| Goodwill | 8 | 14 | 15 | 20 | 22 | 16 | 17 | 15 | 18 | 15 | 15 | 12 |
| Total assets | 148 | 154 | 172 | 198 | 201 | 213 | 218 | 226 | 221 | 210 | 212 | 207 |
| Accounts payable | 7 | 7 | 9 | 17 | 17 | 16 | 15 | 18 | 15 | 16 | 16 | 18 |
| Current portion of long-term debt | — | — | — | — | — | 1 | — | — | — | 2 | — | 2 |
| Total current liabilities | 16 | 18 | 21 | 30 | 30 | 35 | 36 | 40 | 37 | 38 | 44 | 46 |
| Lease liability, non-current | 9 | 9 | 10 | 12 | 11 | 11 | 10 | 9 | 10 | 10 | 10 | 7 |
| Total liabilities | 25 | 30 | 46 | 74 | 77 | 66 | 75 | 79 | 86 | 81 | 82 | 81 |
| Retained earnings | 70 | 69 | 71 | 69 | 69 | 50 | 46 | 47 | 30 | 24 | 24 | 19 |
| Total stockholders' equity | 124 | 123 | 125 | 125 | 125 | 147 | 143 | 147 | 134 | 129 | 131 | 125 |
| Total liabilities and equity | 148 | 154 | 172 | 198 | 201 | 213 | 218 | 226 | 221 | 210 | 212 | 207 |
| Common shares outstanding (cover page) millions of shares | 7 | 7 | 7 | 7 | 7 | 9 | 10 | 10 | 10 | 11 | 10 | 10 |
Cash flows
CSVFiscal quarters (LAKE's year ends in late January)
| In millions of dollars | Oct 31, 2023 | Jan 31, 2024 | Apr 30, 2024 | Jul 31, 2024 | Oct 31, 2024 | Jan 31, 2025 | Apr 30, 2025 | Jul 31, 2025 | Oct 31, 2025 | Jan 31, 2026 | Apr 30, 2026 | Jul 31, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 3 | (1)* | 2 | (1) | 0 | (18)* | (4) | 1 | (16) | (6)* | 0 | (5) |
| Stock-based compensation | 0* | 1* | 0 | 0* | 0* | 0* | 0 | 1* | 1* | 0* | 1 | 1* |
| Depreciation and amortization | — | year only | — | — | — | year only | — | — | — | year only | — | — |
| Net cash from operating activities | 4* | 3* | 0 | (4)* | (8)* | (3)* | (5) | (5)* | (8)* | 2* | 6 | (0)* |
| Purchases of property and equipment | 0* | 1* | 0 | 0* | 1* | 0* | 1 | 1* | (1)* | (0)* | 1 | 0* |
| Net cash from investing activities | (1)* | (2)* | (9) | (15)* | (1)* | (22)* | (1) | (1)* | 1* | 0* | 4 | (0)* |
| Dividends paid | 0* | 0* | 0 | 0* | 0* | 0* | 0 | 0* | 0* | 0* | 0 | 0* |
| Repayments of long-term debt | — | — | — | — | — | year only | — | — | — | year only | — | — |
| Net cash from financing activities | (0)* | (2)* | 12 | 15* | 1* | 28* | 9 | 2* | 7* | (6)* | (5) | 2* |
| Net change in cash | 2* | (1)* | 3 | (3)* | (9)* | 2* | 1 | (1)* | (1)* | (5)* | 5 | 0* |
Compare with peers
SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Lakeland Industries | 18 | 50 | (0.4)* | 9.9M | — | 10-QJul 31, 2026 |
| Picard Medical | 0 | 3 | (1.4)* | 2.3M | 0.0 quarters | 10-QJun 30, 2026 |
| Neuronetics | 19 | 42 | (1)* | 76.2M | 19.0 quarters | 10-QJun 30, 2026 |
| AVITA Medical | 9.1 | 22 | (3.5)* | 30.9M | 3.2 quarters | 10-QJun 30, 2026 |
| InfuSystem Holdings | 1 | 37 | 6.8* | 19.9M | — | 10-QJun 30, 2026 |
| KORU Medical Systems | 8.3 | 12 | 0.2* | 46.2M | — | 10-QJun 30, 2026 |
| Anika Therapeutics | 38 | 33 | (0.7)* | 13.4M | 56.2 quarters | 10-QJun 30, 2026 |
| Sanara MedTech | 15 | 28 | 2* | 9.2M | — | 10-QJun 30, 2026 |
| Stereotaxis | 10 | 7.7 | (3.7)* | 100.2M | 2.9 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.